Literature DB >> 33340244

Interleukin-4 repairs wear particle induced osteolysis by modulating macrophage polarization and bone turnover.

Jukka Pajarinen1,2,3, Tzuhua Lin1, Akira Nabeshima1, Taishi Sato1, Emmanuel Gibon1, Eemeli Jämsen1,3, Tahsin N Khan1, Zhenyu Yao1, Stuart B Goodman1,4.   

Abstract

Periprosthetic osteolysis remains as a major complication of total joint replacement surgery. Modulation of macrophage polarization with interleukin-4 (IL-4) has emerged as an effective means to limit wear particle-induced osteolysis. The aim of this study was to evaluate the efficacy of local IL-4 delivery in treating preexisting particle-induced osteolysis. To this end, recently established 8 week modification of murine continuous femoral intramedullary particle infusion model was utilized. Subcutaneous infusion pumps were used to deliver polyethylene (PE) particles into mouse distal femur for 4 weeks to induce osteolysis. IL-4 was then added to the particle infusion for another 4 weeks. This delayed IL-4 treatment (IL-4 Del) was compared to IL-4 delivered continuously (IL-4 Cont) with PE particles from the beginning and to the infusion of particles alone for 8 weeks. Both IL-4 treatments were highly effective in preventing and repairing preexisting particle-induced bone loss as assessed by μCT. Immunofluorescence indicated a significant reduction in the number of F4/80 + iNOS + M1 macrophages and increase in the number of F4/80 + CD206 + M2 macrophages with both IL-4 treatments. Reduction in the number of tartrate resistant acid phosphatase + osteoclasts and increase in the amount of alkaline phosphatase (ALP) + osteoblasts was also observed with both IL-4 treatments likely explaining the regeneration of bone in these samples. Interesting, slightly more bone formation and ALP + osteoblasts were seen in the IL-4 Del group than in the IL-4 Cont group although these differences were not statistically significant. The study is a proof of principle that osteolytic lesions can be repaired via modulation of macrophage polarization.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  interleukin-4; macrophage polarization; murine model; periprosthetic osteolysis; total joint replacement

Mesh:

Substances:

Year:  2020        PMID: 33340244      PMCID: PMC8213865          DOI: 10.1002/jbm.a.37142

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  51 in total

1.  Establishment of NF-κB sensing and interleukin-4 secreting mesenchymal stromal cells as an "on-demand" drug delivery system to modulate inflammation.

Authors:  Tzuhua Lin; Jukka Pajarinen; Akira Nabeshima; Laura Lu; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  Cytotherapy       Date:  2017-07-21       Impact factor: 5.414

Review 2.  Macrophages-Key cells in the response to wear debris from joint replacements.

Authors:  Christophe Nich; Yuya Takakubo; Jukka Pajarinen; Mari Ainola; Abdelhakim Salem; Tarvo Sillat; Allison J Rao; Milan Raska; Yasunobu Tamaki; Michiaki Takagi; Yrjö T Konttinen; Stuart B Goodman; Jiri Gallo
Journal:  J Biomed Mater Res A       Date:  2013-04-09       Impact factor: 4.396

Review 3.  Mesenchymal stem cells in the aseptic loosening of total joint replacements.

Authors:  Jukka Pajarinen; Tzu-Hua Lin; Akira Nabeshima; Eemeli Jämsen; Laura Lu; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2017-02-01       Impact factor: 4.396

4.  Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K.

Authors:  Jami Mandelin; Tian-Fang Li; Mika Hukkanen; Mikko Liljeström; Jari Salo; Seppo Santavirta; Yrjö T Konttinen
Journal:  J Rheumatol       Date:  2005-04       Impact factor: 4.666

Review 5.  Protective and pathogenic functions of macrophage subsets.

Authors:  Peter J Murray; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2011-10-14       Impact factor: 53.106

6.  Interleukin (IL)-4 and IL-13 inhibit the differentiation of murine osteoblastic MC3T3-E1 cells.

Authors:  K Ura; I Morimoto; K Watanabe; K Saito; N Yanagihara; S Eto
Journal:  Endocr J       Date:  2000-06       Impact factor: 2.349

7.  An in vivo murine model of continuous intramedullary infusion of polyethylene particles.

Authors:  Ting Ma; Zhinong Huang; Pei-Gen Ren; Ryan McCally; Derek Lindsey; R L Smith; Stuart B Goodman
Journal:  Biomaterials       Date:  2008-06-18       Impact factor: 12.479

8.  Soluble and particulate Co-Cr-Mo alloy implant metals activate the inflammasome danger signaling pathway in human macrophages: a novel mechanism for implant debris reactivity.

Authors:  Marco S Caicedo; Ronak Desai; Kyron McAllister; Anand Reddy; Joshua J Jacobs; Nadim J Hallab
Journal:  J Orthop Res       Date:  2009-07       Impact factor: 3.494

Review 9.  Inflammation, fracture and bone repair.

Authors:  Florence Loi; Luis A Córdova; Jukka Pajarinen; Tzu-hua Lin; Zhenyu Yao; Stuart B Goodman
Journal:  Bone       Date:  2016-03-02       Impact factor: 4.398

10.  NFκB sensing IL-4 secreting mesenchymal stem cells mitigate the proinflammatory response of macrophages exposed to polyethylene wear particles.

Authors:  Tzuhua Lin; Yusuke Kohno; Jhih-Fong Huang; Monica Romero-Lopez; Jukka Pajarinen; Masahiro Maruyama; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2018-08-07       Impact factor: 4.396

View more
  3 in total

Review 1.  Macrophage Polarization and the Osteoimmunology of Periprosthetic Osteolysis.

Authors:  Stuart B Goodman; Emmanuel Gibon; Jiri Gallo; Michiaki Takagi
Journal:  Curr Osteoporos Rep       Date:  2022-02-08       Impact factor: 5.096

2.  Titanium alloy composited with dual-cytokine releasing polysaccharide hydrogel to enhance osseointegration via osteogenic and macrophage polarization signaling pathways.

Authors:  Yaping Wang; Zujian Feng; Xiang Liu; Chunfang Yang; Rui Gao; Wenshuai Liu; Wenbin Ou-Yang; Anjie Dong; Chuangnian Zhang; Pingsheng Huang; Weiwei Wang
Journal:  Regen Biomater       Date:  2022-01-12

Review 3.  Overview of First-Line and Second-Line Pharmacotherapies for Osteoarthritis with Special Focus on Intra-Articular Treatment.

Authors:  Alicja Nowaczyk; Dawid Szwedowski; Ignacio Dallo; Jacek Nowaczyk
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.